Tags

Type your tag names separated by a space and hit enter

Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
BMJ Open. 2022 01 03; 12(1):e057127.BO

Abstract

OBJECTIVE

To examine SARS-CoV-2 vaccine confidence, attitudes and intentions in Australian adults as part of the iCARE Study.

DESIGN AND SETTING

Cross-sectional online survey conducted when free COVID-19 vaccinations first became available in Australia in February 2021.

PARTICIPANTS

Total of 1166 Australians from general population aged 18-90 years (mean 52, SD of 19).

MAIN OUTCOME MEASURES

Primary outcome: responses to question 'If a vaccine for COVID-19 were available today, what is the likelihood that you would get vaccinated?'.Secondary outcome: analyses of putative drivers of uptake, including vaccine confidence, socioeconomic status and sources of trust, derived from multiple survey questions.

RESULTS

Seventy-eight per cent reported being likely to receive a SARS-CoV-2 vaccine. Higher SARS-CoV-2 vaccine intentions were associated with: increasing age (OR: 2.01 (95% CI 1.77 to 2.77)), being male (1.37 (95% CI 1.08 to 1.72)), residing in least disadvantaged area quintile (2.27 (95% CI 1.53 to 3.37)) and a self-perceived high risk of getting COVID-19 (1.52 (95% CI 1.08 to 2.14)). However, 72% did not believe they were at a high risk of getting COVID-19. Findings regarding vaccines in general were similar except there were no sex differences. For both the SARS-CoV-2 vaccine and vaccines in general, there were no differences in intentions to vaccinate as a function of education level, perceived income level and rurality. Knowing that the vaccine is safe and effective and that getting vaccinated will protect others, trusting the company that made it and vaccination recommended by a doctor were reported to influence a large proportion of the study cohort to uptake the SARS-CoV-2 vaccine. Seventy-eight per cent reported the intent to continue engaging in virus-protecting behaviours (mask wearing, social distancing, etc) postvaccine.

CONCLUSIONS

Most Australians are likely to receive a SARS-CoV-2 vaccine. Key influencing factors identified (eg, knowing vaccine is safe and effective, and doctor's recommendation to get vaccinated) can inform public health messaging to enhance vaccination rates.

Authors+Show Affiliations

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia joanne.enticott@monash.edu. Monash Partners Academic Health Science Centre, Melbourne, Victoria, Australia.Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.Montreal Behavioural Medicine Centre, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Québec, Canada. Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, Québec, Canada.Montreal Behavioural Medicine Centre, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Québec, Canada. Department of Psychology, University of Quebec in Montreal, Montreal, Québec, Canada.Department of General Practice, Monash University, Clayton, Victoria, Australia.Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia. Monash Partners Academic Health Science Centre, Melbourne, Victoria, Australia.Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia. School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34980631

Citation

Enticott, Joanne, et al. "Attitudes Towards Vaccines and Intention to Vaccinate Against COVID-19: a Cross-sectional Analysis-implications for Public Health Communications in Australia." BMJ Open, vol. 12, no. 1, 2022, pp. e057127.
Enticott J, Gill JS, Bacon SL, et al. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open. 2022;12(1):e057127.
Enticott, J., Gill, J. S., Bacon, S. L., Lavoie, K. L., Epstein, D. S., Dawadi, S., Teede, H. J., & Boyle, J. (2022). Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open, 12(1), e057127. https://doi.org/10.1136/bmjopen-2021-057127
Enticott J, et al. Attitudes Towards Vaccines and Intention to Vaccinate Against COVID-19: a Cross-sectional Analysis-implications for Public Health Communications in Australia. BMJ Open. 2022 01 3;12(1):e057127. PubMed PMID: 34980631.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. AU - Enticott,Joanne, AU - Gill,Jaskirath Singh, AU - Bacon,Simon L, AU - Lavoie,Kim L, AU - Epstein,Daniel S, AU - Dawadi,Shrinkhala, AU - Teede,Helena J, AU - Boyle,Jacqueline, AU - ,, Y1 - 2022/01/03/ PY - 2022/1/4/entrez PY - 2022/1/5/pubmed PY - 2022/1/11/medline KW - COVID-19 KW - infection control KW - preventive medicine KW - public health KW - respiratory infections SP - e057127 EP - e057127 JF - BMJ open JO - BMJ Open VL - 12 IS - 1 N2 - OBJECTIVE: To examine SARS-CoV-2 vaccine confidence, attitudes and intentions in Australian adults as part of the iCARE Study. DESIGN AND SETTING: Cross-sectional online survey conducted when free COVID-19 vaccinations first became available in Australia in February 2021. PARTICIPANTS: Total of 1166 Australians from general population aged 18-90 years (mean 52, SD of 19). MAIN OUTCOME MEASURES: Primary outcome: responses to question 'If a vaccine for COVID-19 were available today, what is the likelihood that you would get vaccinated?'.Secondary outcome: analyses of putative drivers of uptake, including vaccine confidence, socioeconomic status and sources of trust, derived from multiple survey questions. RESULTS: Seventy-eight per cent reported being likely to receive a SARS-CoV-2 vaccine. Higher SARS-CoV-2 vaccine intentions were associated with: increasing age (OR: 2.01 (95% CI 1.77 to 2.77)), being male (1.37 (95% CI 1.08 to 1.72)), residing in least disadvantaged area quintile (2.27 (95% CI 1.53 to 3.37)) and a self-perceived high risk of getting COVID-19 (1.52 (95% CI 1.08 to 2.14)). However, 72% did not believe they were at a high risk of getting COVID-19. Findings regarding vaccines in general were similar except there were no sex differences. For both the SARS-CoV-2 vaccine and vaccines in general, there were no differences in intentions to vaccinate as a function of education level, perceived income level and rurality. Knowing that the vaccine is safe and effective and that getting vaccinated will protect others, trusting the company that made it and vaccination recommended by a doctor were reported to influence a large proportion of the study cohort to uptake the SARS-CoV-2 vaccine. Seventy-eight per cent reported the intent to continue engaging in virus-protecting behaviours (mask wearing, social distancing, etc) postvaccine. CONCLUSIONS: Most Australians are likely to receive a SARS-CoV-2 vaccine. Key influencing factors identified (eg, knowing vaccine is safe and effective, and doctor's recommendation to get vaccinated) can inform public health messaging to enhance vaccination rates. SN - 2044-6055 UR - https://www.unboundmedicine.com/medline/citation/34980631/Attitudes_towards_vaccines_and_intention_to_vaccinate_against_COVID_19:_a_cross_sectional_analysis_implications_for_public_health_communications_in_Australia_ L2 - https://bmjopen.bmj.com/lookup/pmidlookup?view=long&pmid=34980631 DB - PRIME DP - Unbound Medicine ER -